520 search results for “medical drug violence” in the Staff website
-
Protocol for reporting domestic violence and child abuse
In accordance with Article 1.21 of the WHW, Leiden University is obliged to draw up a reporting protocol that students and staff can follow if they perceive signs that students, children, or staff are experiencing domestic violence or child abuse.
-
Training: alcohol- and drug use under students
Training for staff members
-
Training: alcohol and drug use among students
Training for staff members
-
Katharina Krüsselmann
Faculty Governance and Global Affairs
k.krusselmann@fgga.leidenuniv.nl | +31 70 800 9192
-
Sylvia Vink
Leiden Learning and Innovation Centre
c.c.vink@llinc.leidenuniv.nl | +31 71 527 4059
-
Hildert Bronkhorst
Science
h.bronkhorst@biology.leidenuniv.nl | +31 71 527 4964
-
Jeanette Satink
Faculteit Rechtsgeleerdheid
a.e.j.satink@law.leidenuniv.nl | +31 71 527 2727
-
Graig Klein
Faculty Governance and Global Affairs
g.r.e.klein@fgga.leidenuniv.nl | +31 70 800 9506
-
New potential drug suppresses chemotherapy induced neuropathic pain
Oncode Investigator Mario van der Stelt and his colleagues have discovered a new potential drug that suppresses chemotherapy induced neuropathic pain.
-
Evani Lachmansingh
Science
e.t.lachmansingh@liacs.leidenuniv.nl | +31 71 527 2727
-
Alexander Kros
Science
a.kros@chem.leidenuniv.nl | +31 71 527 4234
-
Ernst Dijxhoorn
Faculty Governance and Global Affairs
e.e.a.dijxhoorn@fgga.leidenuniv.nl | +31 70 800 9082
-
Medical Delta AI for Computational Life Sciences
The fact that scientists are increasingly better able to access molecular cell and tissue data also brings with it a new challenge: how can scientists find the information they need for research among the vast amount of data available?
-
Developing drugs with artificial intelligence
Developing new drugs is a difficult process. With the aid of artificial intelligence, Pharmaceutical scientist Xuhan Liu has developed methods that can help make drug design cheaper and faster. PhD defence on 15 February.
-
Jan van Staalduinen
Faculteit Rechtsgeleerdheid
j.h.van.staalduinen@law.leidenuniv.nl | +31 71 527 5139
-
localization of lipid-based nanomedicines for the exploration of targeted drug delivery
PhD defence
-
Peter Bouwman
Science
r.j.p.bouwman@lacdr.leidenuniv.nl | +31 71 527 6105
-
Giulia Callegaro
Science
g.callegaro@lacdr.leidenuniv.nl | +31 71 527 6105
-
Marieke Liem
Faculty Governance and Global Affairs
m.c.a.liem@fgga.leidenuniv.nl | +31 70 800 9935
-
Oncode Accelerator launched: patients at the centre of innovative cancer drug development
Providing each cancer patient with the right treatment remains a challenge. Oncode Accelerator aims to change this by innovating the way we develop cancer treatments, thus ensuring the patient is at the heart of the process.
-
Sabine van der Asdonk
Faculteit der Sociale Wetenschappen
s.van.der.asdonk@fsw.leidenuniv.nl | +31 71 527 5438
-
Sheila van Berkel
Faculteit der Sociale Wetenschappen
berkelsvan@fsw.leidenuniv.nl | +31 71 527 6622
-
Edmund Frettingham
Faculty Governance and Global Affairs
e.j.frettingham@luc.leidenuniv.nl | +31 70 800 9500
-
Kiem project investigates link between violence and other health problems
‘Violence as a Population Health Problem’ is one of 33 interdisciplinary projects that have been launched thanks to a Kiem grant. The project team will analyse a large patient database to identify links between violence and other health problems. ‘Violence can also be an expression of other factors,’…
-
Minor Violence Studies: interesting encounters and flying wooden blocks
The English taught interdisciplinary minor Violence Studies looks into various facets of interpersonal violence. Is this minor for all Leiden students? These two 'colleagues' are certain of it.
-
Bob van de Water
Science
water_b@lacdr.leidenuniv.nl | +31 71 527 6223
-
Medical Delta professor Marco van Vulpen: ‘I advocate the introduction of the share factor’
Proton therapy is a new way of treating cancer in which radiation doses are delivered more precisely. This results in less damage to surrounding tissue and fewer side effects. Professor Marco van Vulpen is medical director of HollandPTC in Delft, where the social value of this therapy is studied. Van…
-
Artificial intelligence as the co-pilot for drug discovery
There are more molecules that could conceivably be candidate drugs than there are stars in the universe. How can we ever efficiently identify those molecules? Professor of AI and Medicinal Chemistry, Gerard van Westen: ‘I’m going to use artificial intelligence as the co-pilot to make an automated search.’…
-
Medical Delta professor Jaap Harlaar: ‘This form of collaboration is in my blood’
Hundreds of thousands of Dutch people suffer from pain caused by knee osteoarthritis and the number is rising fast. Prof. Jaap Harlaar specialises in clinical biomechanics. His research is helping improve osteoarthritis treatment. Harlaar has been appointed Medical Delta Professor and now holds posts…
-
Medical Delta professor Andrew Webb: ‘In The Netherlands, people are much more open to cooperation’
Commercial MRI systems cost millions of euros to purchase and require highly trained technicians to operate. Prof. Andrew Webb works on accessible MRI techniques that offer new opportunities in both developed and developing countries. Webb is a professor at the Radiology Department of the LUMC and,…
-
Medical Delta professor Andrea Evers: ‘I find it important to look for new ways’
Prof. Andrea Evers is a health psychologist who studies the role of behavioural factors in health and disease. As a Medical Delta Professor, she is now affiliated with Leiden University, TU Delft and Erasmus University. In that position, she conducts research at the intersection of various disciplines.…
-
Medical Delta professor Marcel Reinders: ‘You need collaboration to make a real impact’
Prof. Marcel Reinders is a data science specialist at Delft University of technology. Using smart algorithms, he searches for links in complex data. For example, he studies patterns in DNA that lead to aberrant cell behaviour. This knowledge will help detect serious diseases such as Alzheimer's and…
-
LACDR PhD Introductory course on Drug Research
Recently, we had the LACDR PhD Introductory course on Drug Research for starting PhD candidates. It was great to have this live event live in castle Oud Poelgeest, after two years of restrictions.
-
LACDR PhD Introductory course on Drug Research
This week, we had the LACDR PhD Introductory course on Drug. This is always a great opportunity for starting PhD candidates to get to know LACDR, CHDR, the Clinical Pharmacology department of LUMC and the embedding of the institute in the BioSciencepark as a whole.
-
PhD Introductory Course on Drug Research
At the end of February, we had the PhD Introductory Course on Drug Research for starting PhD candidates from LACDR. This 3-days event took place at Castle Oud Poelgeest, a great location to be completely out of the work environment. We welcomed 30 PhD candidates, with whom we had an inspiring and…
- University to raise orange flag against violence against women
-
Laura Heitman
Science
l.h.heitman@lacdr.leidenuniv.nl | +31 71 527 4558
-
LACDR PhD introductory course on drug research
Due to the corona pandemic and the uncertainty of the circumstances end of January 2022, is decided to postpone the LACDR PhD introductory course.
-
LACDR PhD Introductory course on Drug Research
The PhD introductory course will take place on 30 May, 31 May and 1 June 2022 in castle Oud Poelgeest. We are very happy that it will be a live event (as it stands now).
-
Ariane Briegel appointed as Medical Delta professor
Yesterday, eight professors were simultaneously inaugurated as ‘Medical Delta professor’, at Leiden University, LUMC, TU Delft, Erasmus University and Erasmus MC. Ariane Briegel, researcher of the Institute of Biology Leiden of Leiden University, also received the double appointment.
-
Willem Jespers appointed Assistant Professor AI & Structure Based Drug Discovery
Willem Jespers started his position as Assistant Professor in the group of Prof. G.J.P. van Westen on June 1st, a short introduction below:
-
Countering nerve pain caused by chemotherapy with new drug
Nerve pain is one of the most common side effects of chemotherapy. It is therefore one of the biggest reasons for cancer patients to stop treatment early. Darcy Reynolds worked on new drug candidates against this pain during her bachelor's thesis. She developed a new series of molecules that increase…
-
Jennifer Dowling
Faculty Governance and Global Affairs
j.m.dowling@fgga.leidenuniv.nl | +31 70 800 9092
-
Arteriosclerosis and drug discovery: two young researchers win Krijn Rietveld Award for innovative research
One discovered that arteriosclerosis resembles an autoimmune disease, while the other developed a system to aid in the search for new medications. For these achievements, Marie Depuydt and Jurren de Groot were awarded the Krijn Rietveld Memorial Innovation Award on the evening of Tuesday 4 June.
-
Modified caffeine molecules help medical research move forward
Before researchers can develop targeted drugs, they need to know exactly how a disease works. Biochemist Bert Beerkens created molecules that allow them to find out. He used caffeine as the basis for new molecules that enable research into certain receptor proteins on cells.
-
Mario van der Stelt
Science
m.van.der.stelt@chem.leidenuniv.nl | +31 71 527 4768
-
Gerard van Westen
Science
gerard@lacdr.leidenuniv.nl | +31 71 527 3511
-
Eline Dekeyster
Faculteit der Sociale Wetenschappen
e.a.g.dekeyster@fsw.leidenuniv.nl | +31 71 527 2727
-
Roxanne Kieltyka
Science
r.e.kieltyka@chem.leidenuniv.nl | +31 71 527 4441
-
Madeline Kavanagh
Science
m.e.kavanagh@lic.leidenuniv.nl | +31 71 527 3527